AI-powered search
AI-powered search

2023 Fall Clinical Virtual Grand Rounds

2023 Virtual Grand Rounds Session 7: May 24, 2023 - Pediatrics 360: Best Practices and Innovations - Your Questions Answered


In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:

Release Date:

May 25, 2023

Expiration Date:

May 25, 2024

Learning Objectives

At the completion of this activity, participants should be better able to:

  • Discuss treatment options for psoriasis, atopic dermatitis, acne, rare diseases, infestations, hair and nail conditions with patients

  • Describe the differences and comparative advantages of therapeutic options for a variety of pediatric dermatologic conditions

  • Discuss sunscreens, skin care of babies, and management of conditions in skin of color with my patients

  • Recognize, diagnose, and manage patients with staph, strep, hemangiomas, and vascular lesions

Intended Audience

This activity has been designed for dermatologists, pediatric dermatologists, pediatricians, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.

Lawrence Eichenfield, MD

Professor of Dermatology and Pediatrics 
Vice-Chair, Department of Dermatology 
Chief, Pediatric and Adolescent Dermatology 
University of California, San Diego and Rady Children’s Hospital
San Diego, CA

Adelaide Hebert, MD

Professor of Dermatology and Pediatrics
UTHealth McGovern Medical School
Houston, TX

Anthony Mancini, MD

Head, Division of Dermatology
Ann & Robert H. Lurie Children's Hospital of Chicago
Professor of Pediatrics and Dermatology
Northwestern University Feinberg School of Medicine
Chicago, IL

Albert Yan, MD

Professor of Pediatrics and Dermatology
Perelman School of Medicine at the University of Pennsylvania
Emeritus Chief, Pediatric Dermatology
Children’s Hospital of Philadelphia
Philadelphia, PA

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education and CMEsquared. The Institute is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The Institute for Continuing Healthcare Education designates this live and enduring activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures & Disclaimers

Disclosures are as follows:

Lawrence Eichenfield, MD

Grant/Research Support: Abbvie, Arcutis, Castle, Dermavant, Galderma, Incyte, Pfizer, Target

Consultant: AbbVie, Almirall, Arena, Aslan, Dermavant, Eli Lilly, Forte, Galderma, Incyte,Krystal, Leo Pharma, Novartis, Pfizer, Regeneron, Sanofi Genzyme, UCB and Ortho Derm

Speakers’ Bureau or Honoraria: Leo, Incyte, Pfizer, Regeneron, Sanofi

Ownership Interest: Forte (Board of Directors-options); Verrica: Board of Directors (options)

Adelaide A. Hebert, MD

Grant/Research Support: Pfizer, Arcutis, Lilly, AbbVie

Consultant: Pfizer, Arcutis, Almirall, Biofrontera, Galderma, Or

Speakers’ Bureau or Honoraria: Pfizer, Arcuits, Almirall, Incyte, Sun

Anthony J. Mancini, MD

has disclosed that they have no relevant financial relationships with any Ineligible Company in the past 24 months.

Albert C. Yan, MD

has disclosed that they have no relevant financial relationships with any Ineligible Company in the past 24 months.

The Institute discloses that all relevant conflicts have been satisfactorily mitigated.


The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us


Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved